The BIOSECURE Act Enacted: Impact on Partnerships with High-Risk Biotechnology Companies
After failing to pass in the previous Congress, a revised version of the “BIOSECURE Act” (“the Act”) was signed into law by President Trump on December 18, 2025, as Section 851 of the National Defense Authorization Act (“NDAA”) for Fiscal Year 2026 (P.L. 119-60). The new law will restrict US federal procurement and grants involving […]
The post The BIOSECURE Act Becomes Law: Implications for Collaborations with “Biotechnology Companies of Concern” appeared first on Healthcare & Life Sciences Blog.
Read More